ABSTRACT
No disponible
Subject(s)
Male , Aged , Humans , Bronchoscopy , Gastrointestinal Contents , Intubation, Intratracheal/instrumentation , Laryngeal Masks , Airway Obstruction/complications , Intestinal Obstruction/surgery , Laparotomy , Preoperative Care , Optical FibersABSTRACT
OBJECTIVE: To draw pediatrician's attention to the risks of the use of designer drugs among adolescents and to review the problem. MATERIAL AND METHODS: We report the case of a 15-year-old girl admitted for seizures, who rapidly developed acute liver failure and died. Clinical and pathological details are reviewed. COMMENT: The use of designer drugs has increased considerably amongst Spanish adolescents and has been related to deaths in young adults with a variety of symptoms. Differential diagnosis should be made with the adverse effects of recreational drugs when clinical symptoms are confusing and in any unexplained deaths. Information on the effects of designer drugs should be disseminated among the population.
Subject(s)
Chemical and Drug Induced Liver Injury/etiology , Designer Drugs/poisoning , Acute Disease , Adolescent , Fatal Outcome , Female , HumansABSTRACT
Llamar la atención de los pediatras sobre los riesgos del consumo de drogas de diseño entre los adolescentes y revisar el problema. Se presenta el caso clínico de una adolescente de 15 años que ingresa con un cuadro convulsivo y desarrolla una insuficiencia hepática aguda con evolución fatal. Se revisan los detalles clínicos y anatomopatológicos. El consumo de drogas de diseño se ha extendido considerablemente entre la población joven en nuestro país. El consumo de drogas de diseño se ha relacionado con casos de muerte entre jóvenes adultos con manifestaciones diversas. Se debe establecer el diagnóstico diferencial con los efectos secundarios de las drogas recreativas en las situaciones en que la clínica no sea clara y ante cualquier muerte inexplicada. Se debe extender la información sobre las drogas de diseño y sus efectos (AU)
Subject(s)
Adolescent , Male , Infant , Female , Humans , Designer Drugs , Fatal Outcome , Meningitis, Pneumococcal , Respiratory Distress Syndrome , Acute Disease , Chemical and Drug Induced Liver Injury , Hemolytic-Uremic SyndromeSubject(s)
Radiopharmaceuticals , Renal Veins/diagnostic imaging , Technetium Tc 99m Mertiatide , Venous Thrombosis/diagnostic imaging , Acute Disease , Catheterization, Central Venous/adverse effects , Hematuria/etiology , Humans , Infant, Newborn , Radionuclide Imaging , Shock/etiology , Technetium Tc 99m Dimercaptosuccinic AcidABSTRACT
Fungal endocarditis in premature infants has rarely been reported; only 16 cases have been described. We present a fatal case of endocarditis due to Candida albicans in a patient requiring neonatal intensive care and parenteral nutrition via a central venous catheter; there were no preexisting pathological abnormalities. The patient had sepsis with multisystem organ failure, resulting in death. A postmortem examination was performed, and the most important findings are presented. The literature on fungal endocarditis in premature infants is reviewed as well.
